Currently available somatostatin analogs are not good for Graves’ orbitopathy

M. L. Tanda; L. Bartalena

doi:10.1007/bf03344119

Currently available somatostatin analogs are not good for Graves’ orbitopathy

Journal of Endocrinological Investigation ◽

10.1007/bf03344119 ◽

2006 ◽

Vol 29 (5) ◽

pp. 389-390 ◽

Cited By ~ 5

Author(s):

M. L. Tanda ◽

L. Bartalena

Keyword(s):

Somatostatin Analogs ◽

Graves Orbitopathy ◽

Good For

Download Full-text

Somatostatin Analogs in Clinical Practice: A Review

International Journal of Molecular Sciences ◽

10.3390/ijms21051682 ◽

2020 ◽

Vol 21 (5) ◽

pp. 1682 ◽

Cited By ~ 10

Author(s):

Mariana Gomes-Porras ◽

Jersy Cárdenas-Salas ◽

Cristina Álvarez-Escolá

Keyword(s):

Dopamine Agonists ◽

Therapeutic Option ◽

Somatostatin Analogs ◽

Intestinal Fistula ◽

Endocrine Tumors ◽

Congenital Hyperinsulinism ◽

Gastroenteropancreatic Neuroendocrine Tumors ◽

Endocrine Diseases ◽

Digestive Diseases ◽

Graves Orbitopathy

Somatostatin analogs are an invaluable therapeutic option in the diagnosis and treatment of somatotropinomas, thyrotropinomas, and functioning and non-functioning gastroenteropancreatic neuroendocrine tumors. They should also be considered an effective and safe therapeutic alternative to corticotropinomas, gonadotropinomas, and prolactinomas resistant to dopamine agonists. Somatostatin analogs have also shown to be useful in the treatment of other endocrine diseases (congenital hyperinsulinism, Graves’ orbitopathy, diabetic retinopathy, diabetic macular edema), non-endocrine tumors (breast, colon, prostate, lung, and hepatocellular), and digestive diseases (chronic refractory diarrhea, hepatorenal polycystosis, gastrointestinal hemorrhage, dumping syndrome, and intestinal fistula).

Download Full-text

Seti Figure of Merit

International Astronomical Union Colloquium ◽

10.1017/s0252921100015293 ◽

1997 ◽

Vol 161 ◽

pp. 711-717 ◽

Cited By ~ 1

Author(s):

John W. Dreher ◽

D. Kent Cullers

Keyword(s):

Figure Of Merit ◽

Qualitative Difference ◽

Current Generation ◽

Detection Range ◽

Sky Surveys ◽

Independent Observations ◽

Good For

AbstractWe develop a figure of merit for SETI observations which is anexplicitfunction of the EIRP of the transmitters, which allows us to treat sky surveys and targeted searches on the same footing. For each EIRP, we calculate the product of terms measuring the number of stars within detection range, the range of frequencies searched, and the number of independent observations for each star. For a given set of SETI observations, the result is a graph of merit versus transmitter EIRP. We apply this technique to several completed and ongoing SETI programs. The results provide a quantitative confirmation of the expected qualitative difference between sky surveys and targeted searches: the Project Phoenix targeted search is good for finding transmitters in the 109to 1014W range, while the sky surveys do their best at higher powers. Current generation optical SETI is not yet competitive with microwave SETI.

Download Full-text